{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:55:54Z","timestamp":1790700954209,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Pregnancy-onset thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening disease of which diagnosis and management requires experienced multidisciplinary teams. The mechanisms responsible for a deficiency in the disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS13) leading to pregnancy-onset TTP may be congenital or acquired, and studying ADAMTS13 conformation could be of interest. The differential diagnosis between TTP and other pregnancy-associated thrombotic microangiopathies (TMA) is often challenging. Our retrospective multicenter study highlights the significance and the challenges associated with pregnancy-onset TTP and childbirth in terms of diagnosis, obstetric management, and follow-up aspects. Among 1174 pregnancy-onset TMA enrolled in the French Registry for TMA from 2000 to 2020, we identified 108 pregnancy-onset TTP: 52 immune-mediated TTP (iTTP, 48.1%), 27 acquired TTP of unidentified mechanism (uTTP, 25%), and 29 congenital TTP (cTTP, 26.9%). Data show that maternal outcome is good (survival rate: 95%) and fetal outcome is linked to the gestational age at the onset of the disease (survival rate: 75.5%). Three distinct entities with different natural histories emerged: pregnancy-onset iTTP appears similar to idiopathic iTTP, with an open ADAMTS13 conformation, and is marked by a relapse risk independent of subsequent pregnancies; pregnancy-onset uTTP appears to have a different pathophysiology with an unexpected open ADAMTS13 conformation and a very low relapse risk independent of subsequent pregnancies; finally, pregnancy-onset cTTP is characterized by the necessity of pregnancy as a systematic and specific trigger and a need for prophylactic plasmatherapy for subsequent pregnancies. This trial was registered at www.clinicaltrials.gov as #NCT00426686, and at the Health Authority and the French Ministry of Health (P051064\/PHRC AOM05012).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011972","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T16:40:00Z","timestamp":1701448800000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-2349","authenticated-orcid":false,"given":"Nicolas","family":"B\u00e9ranger","sequence":"first","affiliation":[{"name":"1Service d'H\u00e9matologie biologique, H\u00f4pital Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris.Nord, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"2EA-3518, Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[{"name":"3Service d\u2019H\u00e9matologie, Centre de r\u00e9f\u00e9rence des microangiopathies thrombotiques, H\u00f4pital Saint-Antoine, Assistance Publique H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"},{"name":"4INSERM UMRS1138, Centre de Recherche des Cordeliers, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Tsatsaris","sequence":"additional","affiliation":[{"name":"5Maternit\u00e9 Port Royal, H\u00f4pital Cochin, FHU PREMA, Assistance Publique-H\u00f4pitaux de Paris.Centre, Universit\u00e9 de Paris, Paris, France"},{"name":"6INSERM UMR-S 1139, Physiopathologie et pharmacotoxicologie placentaire humaine, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Boisseau","sequence":"additional","affiliation":[{"name":"7Service de G\u00e9n\u00e9tique, CHU de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Prov\u00f4t","sequence":"additional","affiliation":[{"name":"8Service de N\u00e9phrologie, CHRU de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahsou","family":"Delmas","sequence":"additional","affiliation":[{"name":"9Service de N\u00e9phrologie, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Poullin","sequence":"additional","affiliation":[{"name":"10Service d\u2019H\u00e9maph\u00e9r\u00e8se, H\u00f4pital de la Conception, Assistance Publique-H\u00f4pitaux de Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-8277","authenticated-orcid":false,"given":"Karen","family":"Vanhoorelbeke","sequence":"additional","affiliation":[{"name":"11Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Veyradier","sequence":"additional","affiliation":[{"name":"1Service d'H\u00e9matologie biologique, H\u00f4pital Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris.Nord, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"2EA-3518, Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-337X","authenticated-orcid":false,"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"additional","affiliation":[{"name":"1Service d'H\u00e9matologie biologique, H\u00f4pital Lariboisi\u00e8re, Assistance Publique-H\u00f4pitaux de Paris.Nord, Universit\u00e9 Paris Cit\u00e9, Paris, France"},{"name":"2EA-3518, Institut de Recherche Saint-Louis, Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"issue":"19","key":"2024010914090498000_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020005221","article-title":"Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an International Working Group","volume":"136","author":"Fakhouri","year":"2020","journal-title":"Blood"},{"issue":"112","key":"2024010914090498000_bib2","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ki.2008.609","article-title":"The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007)","volume":"75","author":"George","year":"2009","journal-title":"Kidney Int"},{"issue":"19","key":"2024010914090498000_bib3","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood.2019000962","article-title":"How I treat thrombotic thrombocytopenic purpura in pregnancy","volume":"136","author":"Ferrari","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2024010914090498000_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol"},{"issue":"24","key":"2024010914090498000_bib5","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2024010914090498000_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2024010914090498000_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French National Registry for Thrombotic Microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol"},{"issue":"1","key":"2024010914090498000_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/asheducation-2015.1.644","article-title":"Syndromes of thrombotic microangiopathy associated with pregnancy","volume":"2015","author":"George","year":"2015","journal-title":"Hematology"},{"issue":"1","key":"2024010914090498000_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12884-015-0557-5","article-title":"Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease","volume":"15","author":"Delmas","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"2024010914090498000_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2016.04.009","article-title":"Pregnancy-related thrombotic microangiopathies: clues from complement biology","volume":"54","author":"Fakhouri","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"2024010914090498000_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tmrv.2018.08.002","article-title":"Microangiopathic hemolytic anemia in pregnancy","volume":"32","author":"Neave","year":"2018","journal-title":"Transfus Med Rev"},{"issue":"10","key":"2024010914090498000_bib12","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/jth.15030","article-title":"TTP in the setting of pregnancy: the story still has to be written","volume":"18","author":"Coppo","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2024010914090498000_bib13","first-page":"1320","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women","volume":"92","author":"S\u00e1nchez-Luceros","year":"2004","journal-title":"Thromb Haemost"},{"key":"2024010914090498000_bib14","doi-asserted-by":"crossref","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"21","key":"2024010914090498000_bib15","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2024010914090498000_bib16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2024010914090498000_bib17","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"issue":"22","key":"2024010914090498000_bib18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute TTP","volume":"339","author":"Tsai","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024010914090498000_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3324\/haematol.2022.280768","article-title":"ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology (uTTP)","volume":"108","author":"Joly","year":"2023","journal-title":"Haematologica"},{"issue":"9","key":"2024010914090498000_bib20","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1538-7836.2012.04852.x","article-title":"A\u00a0phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom","volume":"10","author":"Camilleri","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6855","key":"2024010914090498000_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"11","key":"2024010914090498000_bib22","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood-2013-11-538900","article-title":"Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura","volume":"123","author":"Jiang","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2024010914090498000_bib23","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/jth.15009","article-title":"Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2024010914090498000_bib24","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/jth.15064","article-title":"Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura","volume":"18","author":"Sakai","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2024010914090498000_bib25","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2024010914090498000_bib26","doi-asserted-by":"crossref","first-page":"101132","DOI":"10.1016\/j.jbc.2021.101132","article-title":"Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity","volume":"297","author":"Ercig","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"16","key":"2024010914090498000_bib27","doi-asserted-by":"crossref","first-page":"eabg4403","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"issue":"17","key":"2024010914090498000_bib28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2018-11-886309","article-title":"Exploring the \u201cminimal\u201d structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering","volume":"133","author":"Zhu","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2024010914090498000_bib29","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-019-11474-5","article-title":"Crystal structure and substrate-induced activation of ADAMTS13","volume":"10","author":"Petri","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"2024010914090498000_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jth.13922","article-title":"An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura","volume":"16","author":"Roose","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024010914090498000_bib31","first-page":"353","article-title":"Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura","volume":"136","author":"Roose","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2024010914090498000_bib32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2024010914090498000_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"2024010914090498000_bib34","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2016-12-758656","article-title":"Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura","volume":"130","author":"Alwan","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2024010914090498000_bib35","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2024010914090498000_bib36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jth.14747","article-title":"Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen","volume":"18","author":"Dekimpe","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024010914090498000_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"11","key":"2024010914090498000_bib38","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1055\/s-0038-1673686","article-title":"ADAMTS13 gene mutations influence ADAMTS13 conformation and disease age-onset in the French Cohort of Upshaw\u2013Schulman syndrome","volume":"118","author":"Joly","year":"2018","journal-title":"Thromb Haemost"},{"issue":"1","key":"2024010914090498000_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/hematology.2021000290","article-title":"How to evaluate and treat the spectrum of TMA syndromes in pregnancy","volume":"2021","author":"Scully","year":"2021","journal-title":"Hematology"},{"issue":"10","key":"2024010914090498000_bib40","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","volume":"104","author":"Van Dorland","year":"2019","journal-title":"Haematologica"},{"issue":"10","key":"2024010914090498000_bib41","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2024010914090498000_bib42","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jth.15010","article-title":"ISTH guidelines for treatment of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024010914090498000_bib43","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1161\/HYPERTENSIONAHA.123.20987","article-title":"High sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"80","author":"B\u00e9ranger","year":"2023","journal-title":"Hypertension"},{"issue":"suppl 1","key":"2024010914090498000_bib44","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1111\/jth.12953","article-title":"Life after acquired thrombotic thrombocytopenic purpura: morbidity, mortality, and risks during pregnancy","volume":"13","author":"Vesely","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2024010914090498000_bib45","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/bjh.17833","article-title":"First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy","volume":"196","author":"K\u00fchne","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"2024010914090498000_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MBC.0000000000001186","article-title":"Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period","volume":"34","author":"Bruzzese","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"2024010914090498000_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bjh.18888","article-title":"A\u00a0safe and effective use of caplacizumab in pregnancy-related acquired thrombotic thrombocytopenic purpura","volume":"202","author":"Odetola","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"2024010914090498000_bib48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjh.18915","article-title":"Caplacizumab: a game changer also in pregnancy-associated immune-mediated thrombotic thrombocytopenic purpura?","volume":"202","author":"Coppo","year":"2023","journal-title":"Br J Haematol"},{"issue":"2","key":"2024010914090498000_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1538-7836.2008.02846.x","article-title":"Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura","volume":"6","author":"Camilleri","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"25","key":"2024010914090498000_bib50","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1056\/NEJMoa2211113","article-title":"Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura","volume":"387","author":"Asmis","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/183\/2180599\/blooda_adv-2023-011972-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/1\/183\/2180599\/blooda_adv-2023-011972-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T09:10:37Z","timestamp":1704791437000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/1\/183\/506386\/Management-and-follow-up-of-pregnancy-onset"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011972","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}